Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RadNet operates over 400 outpatient diagnostic imaging centers across eight U.S. states, performing more than 10 million procedures annually. The company has aggressively expanded its use of artificial intelligence in breast cancer screening and other areas through acquisitions such as iCAD and SeeMode Technologies. Its AI tools are used to double-read mammograms and improve operational efficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rad Imaging.